Clinical Trial
doi: 10.1016/0360-3016(85)90042-2.
A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma
- PMID: 4044346
- DOI: 10.1016/0360-3016(85)90042-2
Item in Clipboard
Clinical Trial
A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma
Int J Radiat Oncol Biol Phys.
1985 Oct.
Abstract
Thirty-five tumors in 14 patients with metastatic or recurrent malignant melanoma were randomized to high dose per fraction radiotherapy at either 9 Gy X 3 or 5 Gy X 8 twice weekly. Complete and persistent regression was found in 24/35 (69%) and partial response in 10/35 of the tumors. The overall response rate was 97%. No difference was observed between the two treatment regimens. Acute and late radiation damage to normal tissue was acceptable and of the same magnitude in both schedules.
Similar articles
-
Some factors of importance in the radiation treatment of malignant melanoma.Radiother Oncol. 1986 Mar;5(3):183-92. doi: 10.1016/s0167-8140(86)80048-2. Radiother Oncol. 1986. PMID: 3085169
-
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology.Int J Hyperthermia. 1996 Jan-Feb;12(1):3-20. doi: 10.3109/02656739609023685. Int J Hyperthermia. 1996. PMID: 8676005 Clinical Trial.
-
Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):607-18. doi: 10.1016/s0360-3016(99)00066-8. Int J Radiat Oncol Biol Phys. 1999. PMID: 10348291
-
Radiation therapy for cutaneous melanoma.Dermatol Clin. 2012 Jul;30(3):525-33. doi: 10.1016/j.det.2012.04.011. Epub 2012 Jun 7. Dermatol Clin. 2012. PMID: 22800556 Free PMC article. Review.
-
[Role and methods of radiotherapy in the treatment of malignant melanoma].Ann Dermatol Venereol. 1991;118(5):393-400. Ann Dermatol Venereol. 1991. PMID: 1897823 Review. French. No abstract available.
Cited by
-
Role of radiotherapy in melanoma management.Radiol Oncol. 2010 Mar;44(1):1-12. doi: 10.2478/v10019-010-0008-x. Epub 2010 Mar 18. Radiol Oncol. 2010. PMID: 22933884 Free PMC article.
-
The evolving role of radiation therapy in the management of malignant melanoma.Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):645-54. doi: 10.1016/j.ijrobp.2010.12.071. Epub 2011 Apr 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 21489712 Free PMC article. Review.
-
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.Radiat Oncol. 2011 Apr 8;6:34. doi: 10.1186/1748-717X-6-34. Radiat Oncol. 2011. PMID: 21477295 Free PMC article.
-
Radiotherapy in the Treatment of Subcutaneous Melanoma.Cancers (Basel). 2021 Nov 22;13(22):5859. doi: 10.3390/cancers13225859. Cancers (Basel). 2021. PMID: 34831017 Free PMC article. Review.
-
Nanosystems for Improved Targeted Therapies in Melanoma.J Clin Med. 2020 Jan 23;9(2):318. doi: 10.3390/jcm9020318. J Clin Med. 2020. PMID: 31979325 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
